Passage Bio, Inc. (PASG)
3.46
-0.05
(-1.42%)
USD |
NASDAQ |
Nov 05, 16:00
Passage Bio Price to Book Value : 2.499 for Nov. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 2.499 |
| November 04, 2026 | 2.535 |
| November 03, 2026 | 2.455 |
| November 02, 2026 | 2.398 |
| October 30, 2026 | 2.491 |
| October 29, 2026 | 2.542 |
| October 28, 2026 | 2.405 |
| October 27, 2026 | 2.419 |
| October 26, 2026 | 2.426 |
| October 23, 2026 | 2.434 |
| October 22, 2026 | 2.535 |
| October 21, 2026 | 2.592 |
| October 20, 2026 | 2.600 |
| October 19, 2026 | 2.585 |
| October 16, 2026 | 2.527 |
| October 15, 2026 | 2.600 |
| October 14, 2026 | 2.643 |
| October 13, 2026 | 2.628 |
| October 12, 2026 | 3.286 |
| October 09, 2026 | 2.665 |
| October 08, 2026 | 2.730 |
| October 07, 2026 | 2.784 |
| October 06, 2026 | 2.946 |
| October 05, 2026 | 2.954 |
| October 02, 2026 | 2.975 |
| Date | Value |
|---|---|
| October 01, 2026 | 3.034 |
| September 30, 2026 | 3.250 |
| September 29, 2026 | 3.344 |
| September 28, 2026 | 3.376 |
| September 25, 2026 | 3.466 |
| September 24, 2026 | 3.466 |
| September 23, 2026 | 3.611 |
| September 22, 2026 | 3.574 |
| September 21, 2026 | 3.488 |
| September 18, 2026 | 3.430 |
| September 17, 2026 | 3.640 |
| September 16, 2026 | 3.510 |
| September 15, 2026 | 3.444 |
| September 14, 2026 | 3.510 |
| September 11, 2026 | 3.611 |
| September 10, 2026 | 3.600 |
| September 09, 2026 | 3.567 |
| September 08, 2026 | 3.502 |
| September 04, 2026 | 3.358 |
| September 03, 2026 | 3.430 |
| September 02, 2026 | 3.329 |
| September 01, 2026 | 3.206 |
| August 31, 2026 | 3.199 |
| August 28, 2026 | 3.264 |
| August 27, 2026 | 3.127 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.752 |
| Alnylam Pharmaceuticals, Inc. | 5.840 |
| Anika Therapeutics, Inc. | 1.652 |
| Savara, Inc. | 6.505 |
| Vericel Corp. | 7.046 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0063 |
| Price | 3.46 |
| Earnings Yield | -326.9% |
| Market Cap | 11.13M |
| PEGY Ratio | -0.0063 |